Amyloid peptides (AMYs) and antimicrobial peptides (AMPs) are considered as the two
distinct families of peptides, characterized by their unique sequences, structures, biological …

The coexistence of amyloid-β (Aβ) and human islet amyloid polypeptide (hIAPP) in the brain
and pancreas is associated with an increased risk of Alzheimer's disease (AD) and type 2 …

Protein misfolding diseases (PMDs) in humans are characterized by the deposition of
protein aggregates in tissues, including Alzheimer's disease, Parkinson's disease, type 2 …

The aggregation of medin forming aortic medial amyloid is linked to arterial wall
degeneration and cerebrovascular dysfunction. Elevated levels of arteriolar medin are …

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common
neurodegenerative diseases with markedly different pathological features of β-amyloid (Aβ) …

An understanding of how the amino acid sequence affects the interaction of peptides with
lipid membranes remains mostly unknown. This type of knowledge is required to rationalize …

The aggregation of α-synuclein is implicated in a number of neurodegenerative diseases,
such as Parkinson's and Multiple System Atrophy, but the role of these aggregates in …

The emergence of antibiotic-resistant bacteria has become a major threat to global public
health and has prompted the discovery of antibiotic alternatives. Natural antimicrobial …

One of the mechanisms accounting for the toxicity of amyloid peptides in diseases like
Alzheimer's and Parkinson's is the formation of pores on the plasma membrane of neurons …